C3 downgrades revenue forecast after delays, low sales

Perth-based burns treatment developer Clinical Cell Culture Ltd, or C3, has announced that lower-than-expected sales and approval delays will keep it from reaching its $5-7 million revenue target for the 2007 financial year.


(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

BNIQ sponsored byECU School of Business and Law


6th-Australian Institute of Management WA20,000
7th-Murdoch University16,584
8th-South Regional TAFE10,549
9th-Central Regional TAFE10,000
10th-The University of Notre Dame Australia6,708
48 tertiary education & training providers ranked by total number of students in WA

Number of Employees

BNiQ Disclaimer